121 related articles for article (PubMed ID: 15175982)
21. Neurological manifestations in Fabry's disease.
Møller AT; Jensen TS
Nat Clin Pract Neurol; 2007 Feb; 3(2):95-106. PubMed ID: 17279083
[TBL] [Abstract][Full Text] [Related]
22. Molecular Pathogenesis of Central and Peripheral Nervous System Complications in Anderson-Fabry Disease.
Tuttolomondo A; Baglio I; Riolo R; Todaro F; Parrinello G; Miceli S; Simonetta I
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203231
[TBL] [Abstract][Full Text] [Related]
23. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
[TBL] [Abstract][Full Text] [Related]
24. [Fabry disease in Italy: first epidemiologic and collaborative study].
Ricci R; Castorina M; Di Lillo M; Antuzzi D; Frustaci A; Parini R; Menni F; Furlan F; Burlina A; Burlina A; Catuogno S; Gabrielli O; Burattini I; Borsini W; Buchner S; Ferriozzi S; Spisni C; De Vito R; Di Rocco M; Aricò M; Pistone G; Bongiorno AM; Morrone A; Cavicchi C; Zammarchi E
Ann Ital Med Int; 2004; 19(4):269-75. PubMed ID: 15678707
[TBL] [Abstract][Full Text] [Related]
25. [Fabry disease].
Jakubowska E; Ryba M; Hruby Z
Przegl Lek; 2006; 63(4):218-9. PubMed ID: 17080745
[TBL] [Abstract][Full Text] [Related]
26. [Fabry disease].
Feriozzi S; Faraggiana T
G Ital Nefrol; 2005; 22 Suppl 33():S34-8. PubMed ID: 16419004
[TBL] [Abstract][Full Text] [Related]
27. Kidney transplantation and enzyme alpha-galactosidase A therapy in patient with Fabry disease: a case report.
Dziemianko I; Jezior D; Boratyńska M; Patrzałek D; Kuźniar J; Szyber P; Klinger M
Transplant Proc; 2007 Nov; 39(9):2925-7. PubMed ID: 18022018
[TBL] [Abstract][Full Text] [Related]
28. Cardiac manifestations of Anderson-Fabry disease in children and adolescents.
Kampmann C; Wiethoff CM; Whybra C; Baehner FA; Mengel E; Beck M
Acta Paediatr; 2008 Apr; 97(4):463-9. PubMed ID: 18363956
[TBL] [Abstract][Full Text] [Related]
29. Functional and structural nerve fiber findings in heterozygote patients with Fabry disease.
Torvin Møller A; Winther Bach F; Feldt-Rasmussen U; Rasmussen A; Hasholt L; Lan H; Sommer C; Kølvraa S; Ballegaard M; Staehelin Jensen T
Pain; 2009 Sep; 145(1-2):237-45. PubMed ID: 19665302
[TBL] [Abstract][Full Text] [Related]
30. The diagnostic workup of patients with neuropathic pain.
Horowitz SH
Med Clin North Am; 2007 Jan; 91(1):21-30. PubMed ID: 17164102
[TBL] [Abstract][Full Text] [Related]
31. Enzyme replacement therapy for Fabry disease: morphologic and histochemical changes in the urinary sediments.
Utsumi K; Mitsuhashi F; Asahi K; Sakurazawa M; Arii K; Komaba Y; Katsumata T; Katsura K; Kase R; Katayama Y
Clin Chim Acta; 2005 Oct; 360(1-2):103-7. PubMed ID: 16112661
[TBL] [Abstract][Full Text] [Related]
32. Fabry disease: a study of 6 hemizygous men and 5 heterozygous women with emphasis on dermatologic manifestations.
Larralde M; Boggio P; Amartino H; Chamoles N
Arch Dermatol; 2004 Dec; 140(12):1440-6. PubMed ID: 15611419
[TBL] [Abstract][Full Text] [Related]
33. Fabry disease: clinical spectrum and evidence-based enzyme replacement therapy.
Desnick RJ; Banikazemi M
Nephrol Ther; 2006 Jan; 2 Suppl 2():S172-85. PubMed ID: 17373219
[TBL] [Abstract][Full Text] [Related]
34. [Stroke in Fabry disease. More than a simple stenosis].
Politei JM
Medicina (B Aires); 2006; 66(5):467-71. PubMed ID: 17137181
[TBL] [Abstract][Full Text] [Related]
35. Two-tier approach for the detection of alpha-galactosidase A deficiency in kidney transplant recipients.
De Schoenmakere G; Poppe B; Wuyts B; Claes K; Cassiman D; Maes B; Verbeelen D; Vanholder R; Kuypers DR; Lameire N; De Paepe A; Terryn W
Nephrol Dial Transplant; 2008 Dec; 23(12):4044-8. PubMed ID: 18596132
[TBL] [Abstract][Full Text] [Related]
36. Hormonal profile and fertility in patients with Anderson-Fabry disease.
Hauser AC; Gessl A; Harm F; Wiesholzer M; Kleinert J; Wallner M; Voigtländer T; Bieglmayer C; Sunder-Plassmann G
Int J Clin Pract; 2005 Sep; 59(9):1025-8. PubMed ID: 16115176
[TBL] [Abstract][Full Text] [Related]
37. Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients.
Navarro C; Teijeira S; Dominguez C; Fernandez JM; Rivas E; Fachal C; Barrera S; Rodriguez C; Iranzo P
Acta Neuropathol; 2006 Feb; 111(2):178-85. PubMed ID: 16463201
[TBL] [Abstract][Full Text] [Related]
38. Anderson-Fabry disease: a case-finding study among male kidney transplant recipients in Austria.
Kleinert J; Kotanko P; Spada M; Pagliardini S; Paschke E; Paul K; Voigtländer T; Wallner M; Kramar R; Stummvoll HK; Schwarz C; Horn S; Holzer H; Födinger M; Sunder-Plassmann G
Transpl Int; 2009 Mar; 22(3):287-92. PubMed ID: 18954370
[TBL] [Abstract][Full Text] [Related]
39. [Psychiatric and neuropsychological signs and symptoms in patients with fabry disease: literature review].
Müller MJ; Müller KM; Dascalescu A; Whybra C; Baron K; Scheurich A; Mann K; Beck M; Schmidt LG; Fellgiebel A
Fortschr Neurol Psychiatr; 2005 Nov; 73(11):687-93. PubMed ID: 16283613
[TBL] [Abstract][Full Text] [Related]
40. Small-fibre neuropathy in female Fabry patients: reduced allodynia and skin blood flow after topical capsaicin.
Moller AT; Feldt-Rasmussen U; Rasmussen AK; Sommer C; Hasholt L; Bach FW; Kølvraa S; Jensen TS
J Peripher Nerv Syst; 2006 Jun; 11(2):119-25. PubMed ID: 16787509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
